ChemicaL NeuroscienceOur lab studies a class of compounds that we call psychoplastogens, or small molecules capable of promoting neural plasticity. Such compounds have enormous potential for treating a wide variety of neuropsychiatric diseases including depression, anxiety disorders, and addiction. We use a combination of synthetic chemistry, molecular neurobiology, and behavioral neuropharmacology to 1) understand the fundamental mechanisms underlying the effects of psychoplastogens on the nervous system, and 2) develop next generation neurotherapeutics.
|
Featured Publications |
help fund OUR RESEARCH
|
|
In this Nature Research Webcast, David presents Olson Lab research on psychoplastogens and discusses these unique molecules with Retsina Meyer and Kurt Rasmussen
|
|
David provides the voiceover for Delix's short video on the therapeutic potential of non-hallucinogenic psychoplastogens
|
David Speaks to Pharmacy Times about psychoplastogens and their potential for treating brain diseases
|
|
Olson Lab research was recognized with the 2021 UC Davis Innovator of the Year Award
|
Click on the link below to listen to David discuss our tabernanthalog work on the bio eats world podcast
|
|
Olson Lab's research led to the founding of Delix Therapeutics. Click on the link below to learn more.
|
Click on the link below to hear David discuss our tabernanthalog work on NPR
|
|
David discusses how research in the Olson Lab led to the formation of Delix Therapeutics
|
Click on the issue of ACS Chemical Neuroscience to Read a NeuroChat profile about David
|
|
David discusses the therapeutic potential of psychedelics on Al Jazeera
|
Listen to David discuss our research on the Academic Minute
|
|
David discusses our research on the BBC
|
Profile of our lab by The Conversation
|
Psy•cho•plast•o•gen
mind + moldable + to produce
mind + moldable + to produce